<table class="infobox infobox-gene">
<tr><th class="infobox-header" colspan="2">SMARCB1</th></tr>
<tr><td class="label">Full Name</td><td>SWI/SNF Related Matrix Associated Actin Dependent Regulator of Chromatin Subfamily B Member 1</td></tr>
<tr><td class="label">Chromosome</td><td>22q11.23</td></tr>
<tr><td class="label">NCBI Gene ID</td><td><a href="https://www.ncbi.nlm.nih.gov/gene/6598" target="_blank">6598</a></td></tr>
<tr><td class="label">Ensembl ID</td><td>ENSG00000099956</td></tr>
<tr><td class="label">OMIM ID</td><td>601607</td></tr>
<tr><td class="label">UniProt ID</td><td><a href="https://www.uniprot.org/uniprot/Q12824" target="_blank">Q12824</a></td></tr>
<tr><td class="label">Associated Diseases</td><td>Schwannomatosis, Rhabdoid Tumors, Coffin-Siris Syndrome, [Alzheimer's Disease](/diseases/alzheimers-disease)</td></tr>
</table>
Overview
Mermaid diagram (expand to render)
SMARCB1 (also known as SNF5, INI1, or BAF47) encodes a core subunit of the SWI/SNF (BAF/PBAF) chromatin remodeling complex, which uses ATP hydrolysis to reposition nucleosomes and regulate gene expression. SMARCB1 is essential for the tumor-suppressive function of SWI/SNF complexes and is one of the most frequently mutated chromatin remodeling genes in human cancer. In the nervous system, SMARCB1 plays critical roles in neural progenitor cell fate determination, Schwann cell differentiation, and neurodevelopmental gene regulation["@kadoch2015"][@versteege1998].
While primarily studied in the context of schwannomatosis and rhabdoid tumors, emerging evidence links SMARCB1-containing SWI/SNF complexes to neurodegenerative disease through their regulation of neuronal gene expression programs, [tau](/proteins/tau) pathology-associated chromatin changes, and epigenetic responses to neuronal stress. The SWI/SNF complex is essential for maintaining the post-mitotic neuronal transcriptional identity that becomes dysregulated in [Alzheimer's disease](/diseases/alzheimers-disease) and other tauopathies["@vogelciernia2019"].
Gene Structure and Expression
SMARCB1 is located on chromosome 22q11.23 and spans approximately 47 kb. The gene encodes a 385-amino acid protein with a molecular weight of approximately 44 kDa. Despite its relatively small size, SMARCB1 serves as a critical scaffold and regulatory subunit of the ~15-subunit BAF complex:
- N-terminal winged helix domain (residues 1-113): Mediates DNA binding and nucleosome recognition, helping target the SWI/SNF complex to specific chromatin contexts
- Repeat 1 (Rpt1) (residues 113-172): Imperfect repeat domain involved in protein-protein interactions within the BAF complex and with transcription factors
- Repeat 2 (Rpt2) (residues 172-245): Second imperfect repeat; Rpt1 and Rpt2 together form a domain that binds acidic patches on the nucleosome surface, anchoring the BAF complex to its substrate
- C-terminal coiled-coil (residues 245-385): Mediates integration into the BAF complex through interactions with [SMARCA4](/genes/smarca4) (BRG1) and [SMARCA2](/genes/smarca2) (BRM) ATPase subunits; essential for BAF complex stability and chromatin remodeling activity
SMARCB1 is ubiquitously expressed, with high levels in neural tissues. During brain development, it is essential in neural progenitor cells for the transition from proliferative npBAF (neuronal progenitor BAF) to post-mitotic nBAF (neuronal BAF) complex composition. In the adult brain, SMARCB1 is expressed in [neurons](/entities/neurons), [oligodendrocytes](/cell-types/oligodendrocytes), and [Schwann cells](/cell-types/schwann-cells), where it maintains lineage-specific gene expression programs[@lessard2007].
Function and Mechanism
SWI/SNF Complex Assembly and Chromatin Remodeling
SMARCB1 is required for the structural integrity and enzymatic activity of both canonical BAF (cBAF) and polybromo-associated BAF (PBAF) complexes. Loss of SMARCB1 destabilizes the complex and shifts the chromatin landscape from an accessible, gene-activating state to a repressive state:
- Enhancer activation: SMARCB1-containing BAF complexes establish and maintain active enhancers by evicting nucleosomes from enhancer elements, enabling transcription factor binding. In neurons, this includes enhancers driving expression of synaptic genes, neurotransmitter receptors, and activity-dependent immediate early genes
- Polycomb antagonism: SMARCB1/BAF complexes directly oppose Polycomb repressive complex 2 (PRC2)-mediated H3K27 trimethylation. Loss of SMARCB1 leads to unchecked PRC2 activity and silencing of neuronal differentiation genes, including those required for maintaining the post-mitotic neuronal state
- Promoter-proximal nucleosome regulation: SMARCB1 positions the BAF complex at the +1 nucleosome of active gene promoters, facilitating RNA Polymerase II pause release and productive transcription elongation
Neural Development and Cell Fate
During CNS development, SMARCB1 orchestrates a switch in SWI/SNF complex composition that is essential for neural progenitor exit from the cell cycle and terminal differentiation:
- In neural progenitors, npBAF complexes containing SMARCB1, BAF53a, and SS18 maintain stemness
- Upon differentiation, npBAF subunits are replaced by nBAF subunits (BAF53b, [CREST](/genes/ss18l1)), while SMARCB1 remains as a constant core component
- SMARCB1 deletion in neural progenitors causes failure to exit the cell cycle and rhabdoid tumor formation; deletion in post-mitotic neurons causes progressive loss of neuronal identity and degeneration
Schwann Cell Biology
SMARCB1 is critical for Schwann cell development and myelination. It drives expression of myelin gene regulatory programs through interactions with SOX10 and EGR2/KROX20 transcription factors. Heterozygous SMARCB1 loss in Schwann cells leads to schwannomatosis, characterized by multiple painful schwannomas[@hulsebos2007].
Disease Associations
Schwannomatosis
Germline SMARCB1 mutations are the most common identified genetic cause of familial schwannomatosis, a condition characterized by multiple schwannomas (benign nerve sheath tumors) causing severe neuropathic pain. Unlike neurofibromatosis type 2 (caused by NF2 mutations), schwannomatosis primarily presents with pain rather than hearing loss. Tumor formation follows a two-hit model: germline heterozygous SMARCB1 mutation plus somatic loss of the remaining allele, typically accompanied by somatic NF2 loss[@hulsebos2007][@plotkin2011].
The pain phenotype in SMARCB1-related schwannomatosis involves both mechanical nerve compression and tumor-secreted pro-nociceptive mediators, making it relevant to understanding pain signaling in neurodegenerative conditions.
Rhabdoid Tumors
Biallelic SMARCB1 inactivation causes atypical teratoid/rhabdoid tumors (AT/RT) of the CNS in infants and young children. These are among the most aggressive pediatric brain tumors, with rhabdoid tumor predisposition syndrome (RTPS1) caused by germline SMARCB1 mutations. The complete absence of SMARCB1 leads to unchecked PRC2 activity and aberrant maintenance of a stem-like transcriptional state.
Coffin-Siris Syndrome
Heterozygous missense mutations in SMARCB1 cause Coffin-Siris syndrome type 3, a neurodevelopmental disorder characterized by intellectual disability, coarse facial features, and fifth digit nail hypoplasia. This demonstrates that even subtle disruption of SMARCB1 function impairs neural development, with affected individuals showing developmental delay and variable neurological features[@tsurusaki2012].
Alzheimer's Disease and Tauopathies
Emerging evidence connects SMARCB1-containing SWI/SNF complexes to AD through several mechanisms:
- [Tau](/proteins/tau)-induced chromatin relaxation: [Tau](/proteins/tau) pathology causes widespread chromatin decondensation and loss of heterochromatin in affected neurons. SWI/SNF complexes, including SMARCB1, are recruited to these aberrantly accessible regions, potentially exhausting the available pool for normal gene regulation at neuronal enhancers
- Epigenetic dysregulation: In AD hippocampal neurons, altered BAF complex activity at enhancers contributes to downregulation of synaptic genes and upregulation of cell cycle genes, a pathological re-entry into the cell cycle that triggers neuronal death
- Polycomb-BAF imbalance: Age-related decline in BAF complex function shifts the balance toward PRC2-mediated repression, silencing neuroprotective genes including [BDNF](/genes/bdnf), activity-regulated genes, and anti-apoptotic factors
- REST regulation: The transcriptional repressor [REST](/genes/rest), which protects aging neurons from degeneration, is a target of BAF-mediated chromatin remodeling; SMARCB1 loss could impair REST-dependent neuroprotection[@vogelciernia2019]
Therapeutic Implications
- EZH2 inhibitors: Since SMARCB1 loss leads to unchecked PRC2/EZH2 activity, EZH2 inhibitors (tazemetostat, approved for epithelioid sarcoma) could theoretically restore the BAF-PRC2 balance in conditions with impaired SMARCB1 function
- BET inhibitors: BAF complex dysfunction can be partially compensated by BET bromodomain inhibitors that modulate enhancer activity through an alternative mechanism
- [HDAC](/entities/hdac-enzymes) inhibitors: Restoring histone acetylation at SMARCB1-dependent enhancers could maintain neuronal gene expression programs during aging
- Gene therapy for schwannomatosis: Restoring SMARCB1 expression in Schwann cells could prevent schwannoma formation and associated neuropathic pain
See Also
- [SMARCA4](/genes/smarca4) — BAF complex ATPase subunit (BRG1)
- [SMARCA2](/genes/smarca2) — BAF complex ATPase subunit (BRM)
- [CHD8](/genes/chd8) — Chromatin remodeler linked to neurodevelopment
- [ATRX](/genes/atrx) — Chromatin remodeler in neurodegeneration
- [REST](/genes/rest) — Neuroprotective transcription factor regulated by BAF complex
- [Epigenetic Mechanisms](/mechanisms/epigenetics-in-neurodegeneration) — Chromatin regulation in disease
External Links
- [NCBI Gene: SMARCB1](https://www.ncbi.nlm.nih.gov/gene/6598)
- [UniProt: Q12824](https://www.uniprot.org/uniprot/Q12824)
- [OMIM: 601607](https://omim.org/entry/601607)
- [GeneCards: SMARCB1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SMARCB1)
- [ClinVar: SMARCB1](https://www.ncbi.nlm.nih.gov/clinvar/?term=SMARCB1%5Bgene%5D)
References
[Unknown, Kadoch & Crabtree, Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics (2015) (2015)](https://doi.org/10.1126/sciadv.1500447)
[Versteege et al., Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer (1998) (1998)](https://doi.org/10.1038/29323)
[Unknown, Vogel-Ciernia & Wood, Neuron-type specific epigenomic reprogramming in Alzheimer's disease (2019) (2019)](https://doi.org/10.1038/s41593-019-0478-1)
[Lessard et al., An essential switch in subunit composition of a chromatin remodeling complex during neural development (2007) (2007)](https://doi.org/10.1016/j.neuron.2007.06.019)
[Hulsebos et al., Germline mutation of INI1/SMARCB1 in familial schwannomatosis (2007) (2007)](https://doi.org/10.1086/519999)
[Plotkin et al., Update from the 2011 International Schwannomatosis Workshop (2013) (2011)](https://doi.org/10.1002/ajmg.a.35903)
[Tsurusaki et al., Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome (2012) (2012)](https://doi.org/10.1038/ng.2219)
[Wilson et al., Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation (2010) (2010)](https://doi.org/10.1016/j.ccr.2010.09.006)
[Unknown, Son & Bhatt, Molecular mechanisms of SWI/SNF complex-mediated chromatin remodeling (2024) (2024)](https://doi.org/10.1146/annurev-biochem-032620-104609)
[Mashtalir et al., Modular organization and assembly of SWI/SNF family chromatin remodeling complexes (2018) (2018)](https://doi.org/10.1016/j.cell.2018.09.032)Pathway Diagram
The following diagram shows the key molecular relationships involving SMARCB1 — SWI/SNF Related Matrix Associated Actin Dependent Regulator of Chromatin Subfamily B Member 1 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)